CT Scan of the Chest: High-Resolution Lung Imaging

Computed tomography (CT) of the chest produces cross-sectional images of the lungs, airways, pleura, mediastinum, and thoracic vasculature at a level of anatomic detail that standard radiography cannot match. High-resolution chest CT (HRCT) protocols extend this capability to characterize parenchymal patterns at sub-millimeter slice thicknesses, making CT the cornerstone imaging tool in pulmonary medicine. Understanding how CT works, when it is ordered, and how it differs from other imaging modalities shapes clinical decision-making across conditions ranging from lung cancer screening to interstitial fibrosis. The regulatory context for pulmonary practice defines specific coverage and quality standards that govern how CT is ordered, performed, and reimbursed.

Definition and Scope

Chest CT is a cross-sectional X-ray technique that rotates an X-ray tube and detector array around the body, acquiring hundreds of projection images that a computer reconstructs into axial slices. Standard chest CT typically uses slice thicknesses of 1–5 mm. High-resolution CT (HRCT) uses thin collimation — typically 0.625–1.25 mm — and a high-spatial-frequency reconstruction algorithm to sharpen the visualization of lung parenchyma, interstitial structures, and small airways.

CT angiography (CTA) of the chest adds timed intravenous contrast injection to opacify pulmonary vasculature, and is the preferred modality for diagnosing pulmonary embolism (sensitivity greater than 95% for central and segmental clots, per guidelines from the American College of Radiology). Low-dose CT (LDCT) uses reduced radiation protocols — as low as 1–2 mSv per acquisition — and is the format mandated by the U.S. Centers for Medicare & Medicaid Services (CMS) for annual lung cancer screening in eligible high-risk adults (CMS National Coverage Determination 210.14).

The principal CT modality variants, classified by protocol and purpose, are:

  1. Standard chest CT — 1–5 mm slices, with or without contrast; evaluates masses, lymphadenopathy, pleural disease
  2. High-resolution CT (HRCT) — ≤1.25 mm slices, no contrast; evaluates interstitial lung disease, bronchiectasis, emphysema pattern
  3. CT pulmonary angiography (CTPA) — contrast-enhanced, timed bolus; evaluates pulmonary embolism and vascular anomalies
  4. Low-dose CT (LDCT) — reduced mA protocols (~1–2 mSv); annual lung cancer screening
  5. CT-guided biopsy — real-time CT fluoroscopy used for percutaneous needle sampling of peripheral lesions

How It Works

A modern multidetector CT (MDCT) scanner acquires data from 64 to 320 simultaneous detector rows, enabling a full chest acquisition in under 5 seconds — short enough to eliminate most respiratory motion artifact when the patient breath-holds. The raw X-ray attenuation data are expressed in Hounsfield units (HU): air measures –1,000 HU, water 0 HU, soft tissue approximately +20 to +80 HU, and cortical bone above +400 HU. Lung parenchyma, which is mostly air, registers between –700 and –900 HU in a healthy adult.

Radiologists apply different "window" settings — combinations of window width and window level — to display the same dataset optimized for lung parenchyma (lung window: width ~1,500 HU, level ~–600 HU) versus mediastinal structures (mediastinal window: width ~350 HU, level ~+40 HU). This single acquisition, dual-interpretation approach means one CT scan yields information about airways, vessels, lymph nodes, and bony structures simultaneously.

For HRCT protocols targeting interstitial lung disease, iterative reconstruction algorithms reduce image noise without increasing radiation dose, a development formalized in guidance from the Radiological Society of North America (RSNA) and American Thoracic Society (ATS) joint statements on ILD imaging.

Radiation dose remains a safety consideration. The National Council on Radiation Protection and Measurements (NCRP) classifies diagnostic CT exposures in its Report No. 160 as the largest contributor to population medical radiation dose in the United States. A standard chest CT delivers approximately 7 mSv effective dose, compared to approximately 0.1 mSv for a chest X-ray. LDCT lung screening protocols reduce this to approximately 1.5 mSv, a threshold validated in the National Lung Screening Trial (NLST).

Common Scenarios

Chest CT is ordered across a wide range of pulmonary and thoracic conditions. The most clinically significant indications include:

Decision Boundaries

Chest CT is not the appropriate first imaging step in every pulmonary scenario. Several structured boundaries define when CT adds value versus when it duplicates or exceeds what is clinically necessary.

CT versus chest X-ray: A chest X-ray remains the first-line modality for uncomplicated pneumonia, routine follow-up of known effusions, and initial triage of respiratory symptoms. CT is indicated when X-ray findings are ambiguous, when a specific anatomic characterization is required before intervention, or when the pre-test probability of a serious finding (mass, embolism, fibrosis) is high. The American College of Radiology (ACR) Appropriateness Criteria, publicly available at ACR.org, provides evidence-graded guidance for these transitions.

HRCT versus standard CT: HRCT is indicated for suspected interstitial lung disease, small airway disease, and bronchiectasis — conditions where parenchymal detail at sub-millimeter resolution changes management. Standard CT suffices for mediastinal adenopathy, pleural disease, and mass characterization, where the additional radiation from maximally thin HRCT slices provides no clinical benefit.

Contrast versus non-contrast: Iodinated IV contrast is required for vascular evaluation (CTPA, aortic pathology) and lymphoma staging, but is withheld in patients with eGFR below thresholds set by the ACR Manual on Contrast Media (typically eGFR <30 mL/min/1.73m² warrants individualized risk-benefit assessment) or documented contrast allergy without adequate premedication.

Lung nodule management: The Fleischner Society 2017 guidelines (Radiology, vol. 284) provide size- and risk-stratified follow-up algorithms for incidentally detected pulmonary nodules. Solid nodules smaller than 6 mm in low-risk individuals require no routine follow-up CT; nodules 6–8 mm warrant repeat CT at 6–12 months; nodules above 8 mm may require PET-CT or tissue sampling. These thresholds directly govern how radiologists and pulmonologists manage incidental findings discovered on CT ordered for other indications.

Patients with abnormal chest X-ray findings are a common entry point for CT referral, and the pulmonaryauthority.com home resource provides additional orientation to the full diagnostic toolkit available in pulmonary medicine. Pediatric CT protocols use substantially reduced dose parameters because children have longer life expectancy and greater radiosensitivity; the Image Gently campaign, coordinated by the Alliance for Radiation Safety in Pediatric Imaging, sets the reference framework for pediatric CT dose optimization.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)